BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38188151)

  • 21. Synergistic Suppression of Glioblastoma Cell Growth by Combined Application of Temozolomide and Dopamine D2 Receptor Antagonists.
    Liu Z; Jiang X; Gao L; Liu X; Li J; Huang X; Zeng T
    World Neurosurg; 2019 Aug; 128():e468-e477. PubMed ID: 31048057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of silencing S-phase kinase-associated protein 2 on chemosensitivity to temozolomide of human glioma cells U251.
    Liu Y; Tang ZG; Yang JQ; Zhou Y; Lin Y; Lv W; Wang GB; Li CL
    Am J Transl Res; 2019; 11(4):2470-2476. PubMed ID: 31105854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Caffeine Inhibits Growth of Temozolomide-Treated Glioma via Increasing Autophagy and Apoptosis but Not via Modulating Hypoxia, Angiogenesis, or Endoplasmic Reticulum Stress in Rats.
    Chen JC; Hwang JH
    Nutr Cancer; 2022; 74(3):1090-1096. PubMed ID: 34060393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypoxia induced ferritin light chain (FTL) promoted epithelia mesenchymal transition and chemoresistance of glioma.
    Liu J; Gao L; Zhan N; Xu P; Yang J; Yuan F; Xu Y; Cai Q; Geng R; Chen Q
    J Exp Clin Cancer Res; 2020 Jul; 39(1):137. PubMed ID: 32677981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cordycepin Augments the Chemosensitivity of Human Glioma Cells to Temozolomide by Activating AMPK and Inhibiting the AKT Signaling Pathway.
    Bi Y; Li H; Yi D; Sun Y; Bai Y; Zhong S; Song Y; Zhao G; Chen Y
    Mol Pharm; 2018 Nov; 15(11):4912-4925. PubMed ID: 30336060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypoxia-Inducible Factor-1α Activity as a Switch for Glioblastoma Responsiveness to Temozolomide.
    Lo Dico A; Martelli C; Diceglie C; Lucignani G; Ottobrini L
    Front Oncol; 2018; 8():249. PubMed ID: 30013951
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synergistic Anticancer Effects of Formononetin and Temozolomide on Glioma C6 Cells.
    Zhang X; Ni Q; Wang Y; Fan H; Li Y
    Biol Pharm Bull; 2018 Aug; 41(8):1194-1202. PubMed ID: 29848900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concomitant treatment with pertussis toxin plus temozolomide increases the survival of rats bearing intracerebral RG2 glioma.
    Magaña-Maldonado R; Manoutcharian K; Hernández-Pedro NY; Rangel-López E; Pérez-De la Cruz V; Rodríguez-Balderas C; Sotelo J; Pineda B
    J Cancer Res Clin Oncol; 2014 Feb; 140(2):291-301. PubMed ID: 24337403
    [TBL] [Abstract][Full Text] [Related]  

  • 29. β-catenin contributes to cordycepin-induced MGMT inhibition and reduction of temozolomide resistance in glioma cells by increasing intracellular reactive oxygen species.
    Bi Y; Li H; Yi D; Bai Y; Zhong S; Liu Q; Chen Y; Zhao G
    Cancer Lett; 2018 Oct; 435():66-79. PubMed ID: 30081068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiosensitizing effect of irisquinone on glioma through the downregulation of HIF-1α evaluated by 18F-FDG and 18F-FMISO PET/CT.
    Wang H; Zhang Y; Yu W; Zhao X; Xue Y; Xu H
    Nucl Med Commun; 2016 Jul; 37(7):705-14. PubMed ID: 26963468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FOXM1-mediated NUF2 expression confers temozolomide resistance to human glioma cells by regulating autophagy via the PI3K/AKT/mTOR signaling pathway.
    Guo L; Wu Z
    Neuropathology; 2022 Oct; 42(5):430-446. PubMed ID: 35701983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of phosphatidylinositol 3-kinase by PX-866 suppresses temozolomide-induced autophagy and promotes apoptosis in glioblastoma cells.
    Harder BG; Peng S; Sereduk CP; Sodoma AM; Kitange GJ; Loftus JC; Sarkaria JN; Tran NL
    Mol Med; 2019 Nov; 25(1):49. PubMed ID: 31726966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sitagliptin inhibits the survival, stemness and autophagy of glioma cells, and enhances temozolomide cytotoxicity.
    You F; Li C; Zhang S; Zhang Q; Hu Z; Wang Y; Zhang T; Meng Q; Yu R; Gao S
    Biomed Pharmacother; 2023 Jun; 162():114555. PubMed ID: 36966667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TRPM8-regulated calcium mobilization plays a critical role in synergistic chemosensitization of Borneol on Doxorubicin.
    Lai H; Liu C; Hou L; Lin W; Chen T; Hong A
    Theranostics; 2020; 10(22):10154-10170. PubMed ID: 32929340
    [No Abstract]   [Full Text] [Related]  

  • 35. Aspirin Affects Tumor Angiogenesis and Sensitizes Human Glioblastoma Endothelial Cells to Temozolomide, Bevacizumab, and Sunitinib, Impairing Vascular Endothelial Growth Factor-Related Signaling.
    Navone SE; Guarnaccia L; Cordiglieri C; Crisà FM; Caroli M; Locatelli M; Schisano L; Rampini P; Miozzo M; La Verde N; Riboni L; Campanella R; Marfia G
    World Neurosurg; 2018 Dec; 120():e380-e391. PubMed ID: 30144594
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thermoresponsive nanocomposite gel for local drug delivery to suppress the growth of glioma by inducing autophagy.
    Ding L; Wang Q; Shen M; Sun Y; Zhang X; Huang C; Chen J; Li R; Duan Y
    Autophagy; 2017 Jul; 13(7):1176-1190. PubMed ID: 28594260
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Irradiation and hypoxia promote homing of haematopoietic progenitor cells towards gliomas by TGF-beta-dependent HIF-1alpha-mediated induction of CXCL12.
    Tabatabai G; Frank B; Möhle R; Weller M; Wick W
    Brain; 2006 Sep; 129(Pt 9):2426-35. PubMed ID: 16835250
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Knockdown lncRNA CRNDE enhances temozolomide chemosensitivity by regulating autophagy in glioblastoma.
    Zhao Z; Liu M; Long W; Yuan J; Li H; Zhang C; Tang G; Jiang W; Yuan X; Wu M; Liu Q
    Cancer Cell Int; 2021 Aug; 21(1):456. PubMed ID: 34454479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Natural borneol sensitizes human glioma cells to cisplatin-induced apoptosis by triggering ROS-mediated oxidative damage and regulation of MAPKs and PI3K/AKT pathway.
    Cao WQ; Zhai XQ; Ma JW; Fu XQ; Zhao BS; Zhang P; Fu XY
    Pharm Biol; 2020 Dec; 58(1):72-79. PubMed ID: 31875760
    [No Abstract]   [Full Text] [Related]  

  • 40. Identification of imaging biomarkers for the assessment of tumour response to different treatments in a preclinical glioma model.
    Lo Dico A; Martelli C; Valtorta S; Raccagni I; Diceglie C; Belloli S; Gianelli U; Vaira V; Politi LS; Bosari S; Lucignani G; Moresco RM; Ottobrini L
    Eur J Nucl Med Mol Imaging; 2015 Jun; 42(7):1093-105. PubMed ID: 25813354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.